{"id":"standard-blood-components","safety":{"commonSideEffects":[{"rate":null,"effect":"Transfusion reaction (acute hemolytic)"},{"rate":null,"effect":"Febrile non-hemolytic transfusion reaction"},{"rate":null,"effect":"Allergic reaction"},{"rate":null,"effect":"Transfusion-related acute lung injury (TRALI)"},{"rate":null,"effect":"Infection transmission risk"},{"rate":null,"effect":"Iron overload (with chronic transfusion)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Standard blood components include red blood cells, platelets, plasma, and clotting factors that are transfused to patients with deficiencies due to bleeding, anemia, or bone marrow disorders. These components restore oxygen-carrying capacity, hemostasis, and essential plasma proteins necessary for normal physiological function.","oneSentence":"Standard blood components restore normal blood function by replacing deficient or dysfunctional cellular and protein elements.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:09:04.864Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute blood loss and hemorrhage"},{"name":"Anemia requiring transfusion"},{"name":"Thrombocytopenia"},{"name":"Coagulation factor deficiency"},{"name":"Support during surgery or trauma"}]},"trialDetails":[{"nctId":"NCT07494955","phase":"NA","title":"\"Effect of Pre-Spinal Mindfulness-Based Breathing Exercise on Hemodynamic Response in Elective Cesarean Section\"","status":"RECRUITING","sponsor":"Aysenur Dostbil","startDate":"2026-03-01","conditions":"Hypotension, Cesarean Section, Hemodynamic Instability","enrollment":150},{"nctId":"NCT03226704","phase":"","title":"Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing","status":"ENROLLING_BY_INVITATION","sponsor":"National Cancer Institute (NCI)","startDate":"2017-08-14","conditions":"Leukemia, Lymphoma, Acute Lymphoblastic Leukemia","enrollment":120},{"nctId":"NCT06323044","phase":"NA","title":"MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2025-02-11","conditions":"Acute Lymphoblastic Leukemia","enrollment":150},{"nctId":"NCT03037164","phase":"PHASE3","title":"INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cerus Corporation","startDate":"2017-05-11","conditions":"Anemia","enrollment":692},{"nctId":"NCT06850688","phase":"NA","title":"Impact of Ambulatory Continuous Monitoring Using Remote Monitoring Medicine Within Patient's Care Pathway Following Colorectal Surgery (CONTACT-GRECCAR 21)","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2025-06-17","conditions":"Colorectal Surgery, Readmission","enrollment":362},{"nctId":"NCT05253651","phase":"PHASE3","title":"A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"Seagen, a wholly owned subsidiary of Pfizer","startDate":"2022-10-24","conditions":"Colorectal Neoplasms","enrollment":400},{"nctId":"NCT06691880","phase":"NA","title":"Feasibility of Video Gaming Technology for Arm Recovery Early Post-stroke","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-03-12","conditions":"Subacute Stroke, Acute Stroke","enrollment":58},{"nctId":"NCT06186401","phase":"PHASE1","title":"Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells","status":"RECRUITING","sponsor":"Hideho Okada, MD, PhD","startDate":"2024-04-30","conditions":"EGFR Gene Mutation, Glioblastoma, MGMT-Unmethylated Glioblastoma","enrollment":20},{"nctId":"NCT06930352","phase":"PHASE2","title":"Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy","status":"NOT_YET_RECRUITING","sponsor":"Uma Borate","startDate":"2026-04-10","conditions":"Acute Myeloid Leukemia","enrollment":70},{"nctId":"NCT06059391","phase":"PHASE2","title":"CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-12","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia","enrollment":216},{"nctId":"NCT07460024","phase":"NA","title":"Implementation of Timely Management of Sepsis and Septic Shock Protocol in the Emergency Department and Intensive Care Unit: A Quality Improvement Project at AFHJ","status":"NOT_YET_RECRUITING","sponsor":"Al-Azhar University","startDate":"2026-03","conditions":"Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome (SIRS)","enrollment":120},{"nctId":"NCT07457866","phase":"NA","title":"Rehab Study for alloBMT Patients","status":"RECRUITING","sponsor":"Jennifer Jones","startDate":"2025-10-01","conditions":"Allogenic Bone Marrow Transplantation","enrollment":208},{"nctId":"NCT05934448","phase":"PHASE2","title":"Pembro Plus CAR T-cell Therapy in R/R in PMBCL","status":"RECRUITING","sponsor":"Jennifer Crombie, MD","startDate":"2023-11-15","conditions":"Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma Refractory","enrollment":35},{"nctId":"NCT07042438","phase":"PHASE2","title":"Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-02-11","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma","enrollment":56},{"nctId":"NCT06111508","phase":"NA","title":"The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2023-11-29","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT05679401","phase":"PHASE3","title":"A Study With Imlifidase in Anti-GBM Disease","status":"TERMINATED","sponsor":"Hansa Biopharma AB","startDate":"2022-12-22","conditions":"Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome","enrollment":50},{"nctId":"NCT07437755","phase":"NA","title":"Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cirrhosis Undergoing Invasive Procedures","status":"RECRUITING","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2025-06-01","conditions":"Liver Cirrhosis With Acute Decompensation","enrollment":116},{"nctId":"NCT07075588","phase":"NA","title":"Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-03-20","conditions":"Hypertension, Hypertension Complicated With Type 2 Diabetes","enrollment":100},{"nctId":"NCT06346886","phase":"NA","title":"HTN App for HTN Control and Cardiovascular Health Among African-Americans","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-05-15","conditions":"Hypertension","enrollment":100},{"nctId":"NCT07435233","phase":"NA","title":"Different Reality Simulation Education Methods on Nursing Students","status":"ACTIVE_NOT_RECRUITING","sponsor":"Karadeniz Technical University","startDate":"2026-01-01","conditions":"Simulation Training","enrollment":102},{"nctId":"NCT03942328","phase":"PHASE1, PHASE2","title":"Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2019-09-19","conditions":"Stage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8","enrollment":85},{"nctId":"NCT07428993","phase":"PHASE2","title":"Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma","status":"NOT_YET_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2026-02","conditions":"Pediatric Osteosarcoma","enrollment":41},{"nctId":"NCT05432635","phase":"PHASE1","title":"Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2023-08-01","conditions":"B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma","enrollment":15},{"nctId":"NCT07373379","phase":"NA","title":"Blended Resources for Integrated Diabetes Guidance and Empowerment","status":"NOT_YET_RECRUITING","sponsor":"Peking University","startDate":"2026-03-01","conditions":"Type 2 Diabetes Mellitus","enrollment":1200},{"nctId":"NCT07425093","phase":"NA","title":"Investigation of the Relationship Between Gray and White Matter Volumes, Walking Exercise, and Body Fat Percentage in Adults With a Body Mass Index Above 25","status":"COMPLETED","sponsor":"Amasya University","startDate":"2024-01-01","conditions":"Obesity & Overweight, Headache, Sedentary Lifestyle","enrollment":22},{"nctId":"NCT07424118","phase":"NA","title":"REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription","status":"NOT_YET_RECRUITING","sponsor":"Evelyn Vanina Re","startDate":"2026-04","conditions":"Essential Hypertension","enrollment":240},{"nctId":"NCT04684719","phase":"PHASE3","title":"Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial","status":"COMPLETED","sponsor":"Jason Sperry","startDate":"2022-04-19","conditions":"Hemorrhagic Shock, Traumatic Injury","enrollment":1020},{"nctId":"NCT07398599","phase":"NA","title":"Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2026-02-15","conditions":"Leptomeningeal Metastasis, Lung Neoplasms, Non-Small Cell Lung Cancer","enrollment":30},{"nctId":"NCT06918977","phase":"NA","title":"Improving Glycemic Control With Telemedicine and Smart Insulin Pens","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-01-30","conditions":"Diabetes Mellitus","enrollment":50},{"nctId":"NCT06095960","phase":"NA","title":"Telehealth Multi-Component Optional Model (MOM) Study","status":"RECRUITING","sponsor":"University of Arkansas","startDate":"2024-02-12","conditions":"Maternal Health","enrollment":1500},{"nctId":"NCT05800405","phase":"EARLY_PHASE1","title":"Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2023-07-20","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma","enrollment":9},{"nctId":"NCT06205225","phase":"NA","title":"iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2024-10-04","conditions":"Heart Failure","enrollment":360},{"nctId":"NCT07374744","phase":"NA","title":"Effect of Interactive Video-Based Self-Management Education in Adults With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Abant Izzet Baysal University","startDate":"2026-08-01","conditions":"Type 2 Diabetes, Outpatient","enrollment":60},{"nctId":"NCT06834373","phase":"PHASE2","title":"Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-04-02","conditions":"Large B-Cell Lymphoma With IRF4 Rearrangement, Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma, Recurrent ALK-Positive Large B-Cell Lymphoma","enrollment":41},{"nctId":"NCT04991870","phase":"PHASE1","title":"Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-04-28","conditions":"Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma","enrollment":25},{"nctId":"NCT07164040","phase":"","title":"Leica Microsystems Sponsored Study to Collect and Confirm Clinical Data on the Performance of the GLOW800 Device When Used in Accordance With Its Intended Use.","status":"RECRUITING","sponsor":"Leica Microsystems (Schweiz) AG","startDate":"2026-01-20","conditions":"Reconstructive Surgical Procedures, Plastic Surgery, Vascular Surgical Procedure","enrollment":29},{"nctId":"NCT04404530","phase":"","title":"Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)","status":"RECRUITING","sponsor":"Emory University","startDate":"2019-10-08","conditions":"Phenylketonurias","enrollment":45},{"nctId":"NCT07329959","phase":"PHASE1","title":"CAR-DC for End-Stage IPF","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-02-01","conditions":"Idiopathic Pulmonary Fibrosis(IPF)","enrollment":8},{"nctId":"NCT02870907","phase":"PHASE2","title":"Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Curie","startDate":"2010-03-18","conditions":"Retinoblastoma","enrollment":195},{"nctId":"NCT07318740","phase":"NA","title":"Effectiveness of Mobile Application-Supported Education and Counseling in Pregnant Women With Gestational Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saglik Bilimleri Universitesi","startDate":"2025-08-18","conditions":"Gestational Diabetes Mellitus (GDM)","enrollment":94},{"nctId":"NCT02782546","phase":"PHASE2","title":"Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2017-01-30","conditions":"Acute Myeloid Leukemia","enrollment":60},{"nctId":"NCT07137312","phase":"","title":"Ex Vivo Expansion (ACT-X)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-12-16","conditions":"Solid Tumor, Healthy, Malignant Solid Neoplasm","enrollment":24},{"nctId":"NCT03013998","phase":"PHASE1, PHASE2","title":"Study of Biomarker-Based Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Beat AML, LLC","startDate":"2016-11","conditions":"Previously Untreated Relapsed Refractory Acute Myeloid Leukemia","enrollment":3000},{"nctId":"NCT07087860","phase":"PHASE2","title":"Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-01","conditions":"Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Refractory Bladder Urothelial Carcinoma","enrollment":70},{"nctId":"NCT02570542","phase":"PHASE2","title":"Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-10","conditions":"Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma (DLBCL)","enrollment":59},{"nctId":"NCT06047171","phase":"PHASE2","title":"Rescue of Nephrons With ALE.F02 (RENAL-F02)","status":"RECRUITING","sponsor":"Alentis Therapeutics AG","startDate":"2023-09-07","conditions":"Glomerulonephritis Rapidly Progressive","enrollment":80},{"nctId":"NCT06418880","phase":"PHASE3","title":"Automated Insulin Delivery for Inpatients With Dysglycemia","status":"COMPLETED","sponsor":"Emory University","startDate":"2025-01-22","conditions":"Type 1 Diabetes, Type 2 Diabetes","enrollment":130},{"nctId":"NCT05120544","phase":"NA","title":"Expanding Technology-Enabled Nurse Delivered Chronic Disease Care","status":"COMPLETED","sponsor":"Duke University","startDate":"2022-04-21","conditions":"Diabetes Mellitus, Type 2, Hypertension","enrollment":220},{"nctId":"NCT06735690","phase":"EARLY_PHASE1","title":"Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2025-06-09","conditions":"Acute Lymphoblastic Leukemia","enrollment":15},{"nctId":"NCT01526096","phase":"PHASE1","title":"Stem Cell Transplantation for Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2011-07-12","conditions":"Myeloma","enrollment":30},{"nctId":"NCT05405426","phase":"NA","title":"Trial of Indication-Based Transfusion of Red Blood Cells in ECMO","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2023-04-14","conditions":"Extracorporeal Membrane Oxygenation, Red Blood Cell Transfusion, Organ Failure, Multiple","enrollment":228},{"nctId":"NCT03520686","phase":"PHASE3","title":"Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2018-05-18","conditions":"Non Small Cell Lung Cancer","enrollment":1538},{"nctId":"NCT07015437","phase":"PHASE2","title":"A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1","status":"RECRUITING","sponsor":"Cerus Corporation","startDate":"2025-09-19","conditions":"Healthy Subjects","enrollment":70},{"nctId":"NCT05416372","phase":"NA","title":"Engaging Religious Leaders to Reduce Blood Pressures in Tanzanian Communities","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2022-06-22","conditions":"Hypertension","enrollment":24000},{"nctId":"NCT04074187","phase":"PHASE2, PHASE3","title":"A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-10-21","conditions":"Thrombotic Thrombocytopenic Purpura","enrollment":21},{"nctId":"NCT05671302","phase":"NA","title":"Walk Together: A Family-Based Intervention for Hypertension In African Americans","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-04-05","conditions":"Hypertension, Family Relations","enrollment":62},{"nctId":"NCT04198857","phase":"NA","title":"Development and Testing of a Mobile Health Application for Management of Gestational Diabetes","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2021-10-18","conditions":"Diabetes, Gestational, Telemedicine","enrollment":220},{"nctId":"NCT03763643","phase":"EARLY_PHASE1","title":"PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-07-01","conditions":"Focal Segmental Glomerulosclerosis","enrollment":21},{"nctId":"NCT05208450","phase":"NA","title":"Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks","status":"ENROLLING_BY_INVITATION","sponsor":"NYU Langone Health","startDate":"2025-06-12","conditions":"Hypertension (HTN)","enrollment":500},{"nctId":"NCT06912529","phase":"PHASE2","title":"Axicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma","status":"TERMINATED","sponsor":"Universität Münster","startDate":"2025-03-13","conditions":"B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent","enrollment":1},{"nctId":"NCT04066959","phase":"NA","title":"Improving Diabetes in Emerging Adulthood","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2020-11-16","conditions":"Diabetes Mellitus, Type 1","enrollment":113},{"nctId":"NCT05093075","phase":"PHASE2","title":"Therapeutic Plasma Exchange in Septic Shock: A Pilot Study","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-06-01","conditions":"Septic Shock","enrollment":80},{"nctId":"NCT07127718","phase":"PHASE2","title":"Preventive Strategies for Early and Late Complications of Leptospirosis","status":"RECRUITING","sponsor":"National Kidney and Transplant Institute, Philippines","startDate":"2024-04-12","conditions":"Leptospirosis","enrollment":678},{"nctId":"NCT05984030","phase":"NA","title":"Supporting Tailored And Responsive PrEP in Rural North Carolina","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-08-31","conditions":"HIV Pre-Exposure Prophylaxis","enrollment":17},{"nctId":"NCT01688492","phase":"PHASE1, PHASE2","title":"Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-09","conditions":"Prostate Cancer","enrollment":54},{"nctId":"NCT07114835","phase":"NA","title":"Low-Intensity BFR Cycling: Impact on VO₂Max and Muscle Adaptations","status":"COMPLETED","sponsor":"Kahramanmaras Sutcu Imam University","startDate":"2023-12-01","conditions":"Aerobic Capacity, Blood Flow Restriction (BFR) Training Effects, Blood Flow Restriction Exercise","enrollment":24},{"nctId":"NCT07111260","phase":"NA","title":"Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-07-01","conditions":"End Stage Renal Disease on Dialysis","enrollment":34},{"nctId":"NCT05081063","phase":"PHASE3","title":"Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients","status":"COMPLETED","sponsor":"Loma Linda University","startDate":"2022-03-05","conditions":"Hemorrhagic Shock, Acute Blood Loss Anemia, Traumatic Brain Injury","enrollment":199},{"nctId":"NCT06819839","phase":"NA","title":"Community-led Strategy to Reduce Cardiovascular Disease Risk Among Conflict-affected Populations","status":"COMPLETED","sponsor":"Community Partners International","startDate":"2024-10-27","conditions":"Cardiovascular Diseases, Hypertension, Diabetes","enrollment":213},{"nctId":"NCT06391073","phase":"NA","title":"Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-07-22","conditions":"Hypertension","enrollment":500},{"nctId":"NCT05429099","phase":"PHASE2, PHASE3","title":"Mandibular Reconstruction Preplanning (ViPMR)","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2022-10-15","conditions":"Oral Cavity Cancer, Oral Cancer","enrollment":420},{"nctId":"NCT04094168","phase":"PHASE4","title":"Clinical Impact of Del Nido Cardioplegia in Adult Cardiac Surgery","status":"COMPLETED","sponsor":"JESSICA GARCIA SUAREZ","startDate":"2018-06-15","conditions":"Heart; Surgery, Heart, Functional Disturbance as Result","enrollment":474},{"nctId":"NCT04935177","phase":"PHASE3","title":"Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx","status":"COMPLETED","sponsor":"Hansa Biopharma AB","startDate":"2021-10-14","conditions":"Kidney Transplantation in Highly Sensitized Patients","enrollment":64},{"nctId":"NCT06834633","phase":"NA","title":"Nephroprotection in Severe Trauma Patients With Kidney Stress","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-07-09","conditions":"Trauma; Complications","enrollment":523},{"nctId":"NCT06815029","phase":"PHASE1","title":"Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2025-06-17","conditions":"Recurrent Astrocytoma, IDH-Mutant, Grade 3, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Recurrent Glioblastoma","enrollment":27},{"nctId":"NCT04548843","phase":"PHASE1","title":"A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion","status":"WITHDRAWN","sponsor":"Minovia Therapeutics Ltd.","startDate":"2022-03-01","conditions":"Primary Mitochondrial Diseases","enrollment":""},{"nctId":"NCT07025941","phase":"NA","title":"Impact of Comprehensive Rehabilitation Nursing Combined With Refined Airway Management and Nutritional Support on Prognosis and Care Delivery Models in Critically Ill Patients","status":"COMPLETED","sponsor":"Taizhou Hospital of Traditional Chinese Medicine","startDate":"2023-06-02","conditions":"Critically Ill Patients, Nutritional Support, Pulmonary Infections","enrollment":101},{"nctId":"NCT07020689","phase":"","title":"Transdisciplinary Intervention for Obesity Hypoventilation Syndrome","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2022-09-01","conditions":"Obesity Hypoventilation Syndrome (OHS), Obstructive Sleep Apnea (OSA)","enrollment":36},{"nctId":"NCT05662462","phase":"NA","title":"Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-11","conditions":"Pre-Gestational Diabetes, Type2diabetes, Pregnancy in Diabetic","enrollment":124},{"nctId":"NCT06644573","phase":"PHASE1","title":"Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Nyree Penn","startDate":"2025-11-01","conditions":"Chronic Insomnia, Sleep Deprivation, REM Behavior Disorder","enrollment":100},{"nctId":"NCT06572631","phase":"PHASE1","title":"Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor","status":"WITHDRAWN","sponsor":"City of Hope Medical Center","startDate":"2025-06-07","conditions":"Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia","enrollment":""},{"nctId":"NCT06985095","phase":"NA","title":"Evaluation of a Structured Nutrition Educational Program in Insulin-treated Diabetic Patients in Vietnam","status":"RECRUITING","sponsor":"Cho Ray Hospital","startDate":"2025-04-04","conditions":"Diabetes Mellitus","enrollment":115},{"nctId":"NCT06952361","phase":"","title":"Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients","status":"COMPLETED","sponsor":"Ardak Arynov","startDate":"2019-03-08","conditions":"Anemia, Blood Transfusion, Cancer","enrollment":107},{"nctId":"NCT03623373","phase":"PHASE2","title":"Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2018-11-29","conditions":"Mantle Cell Lymphoma","enrollment":13},{"nctId":"NCT06621914","phase":"NA","title":"Is Low-load Resistance Training With Blood Flow Restriction Feasible During Rehabilitation of Military Personnel With Lower Limb Injuries? Phase One RCT.","status":"RECRUITING","sponsor":"Defence Medical Rehabilitation Centre, UK","startDate":"2024-10-28","conditions":"Pain, Persistent Pain, Musculoskeletal Pain","enrollment":28},{"nctId":"NCT06621953","phase":"NA","title":"Is Low-load Resistance Training With Blood Flow Restriction More Effective Than Traditional Rehabilitation of Military Personnel With Lower Limb Injuries","status":"NOT_YET_RECRUITING","sponsor":"Defence Medical Rehabilitation Centre, UK","startDate":"2025-06-30","conditions":"Pain, Persistent Pain, Musculoskeletal Pain","enrollment":26},{"nctId":"NCT04685655","phase":"NA","title":"RescuE pLAsma eXchange in Severe COVID-19","status":"TERMINATED","sponsor":"Heidelberg University","startDate":"2020-01-07","conditions":"Therapeutic Plasma Exchange, Covid19","enrollment":67},{"nctId":"NCT03994783","phase":"PHASE3","title":"Transplant Antibody-Mediated Rejection: Guiding Effective Treatments","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2019-07-17","conditions":"Kidney Transplant Rejection, Antibody-mediated Rejection","enrollment":3},{"nctId":"NCT03890237","phase":"NA","title":"GAGE Act With Her-Ethiopia Evaluation","status":"ACTIVE_NOT_RECRUITING","sponsor":"George Washington University","startDate":"2019-03-01","conditions":"Adolescent Behavior, Gender","enrollment":4500},{"nctId":"NCT02711826","phase":"PHASE1, PHASE2","title":"Treg Therapy in Subclinical Inflammation in Kidney Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-09-20","conditions":"Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant","enrollment":32},{"nctId":"NCT05167734","phase":"PHASE2","title":"Practical Anemia Bundle for SusTained Blood Recovery","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2021-11-30","conditions":"Anemia, Critical Illness","enrollment":100},{"nctId":"NCT05726825","phase":"NA","title":"Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock","status":"RECRUITING","sponsor":"Hannover Medical School","startDate":"2025-02-19","conditions":"Septic Shock","enrollment":274},{"nctId":"NCT06187220","phase":"","title":"Plasma Exchange for Amanita Toxin-induced Acute Liver Failure","status":"COMPLETED","sponsor":"Hannover Medical School","startDate":"2024-01-01","conditions":"Acute Liver Failure","enrollment":111},{"nctId":"NCT06495294","phase":"NA","title":"SWiFT Canada (Study of Whole Blood in Frontline Trauma)","status":"RECRUITING","sponsor":"Unity Health Toronto","startDate":"2024-12-16","conditions":"Trauma","enrollment":60},{"nctId":"NCT04406441","phase":"NA","title":"Patient-Clinic-Community Integration to Prevent Obesity Among Rural Preschool Children","status":"COMPLETED","sponsor":"Geisinger Clinic","startDate":"2020-08-17","conditions":"Pediatric Obesity, Preventive Medicine, Mentoring","enrollment":2040},{"nctId":"NCT06855667","phase":"NA","title":"Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2025-03-03","conditions":"Autoimmune Hepatitis","enrollment":50},{"nctId":"NCT04663061","phase":"NA","title":"Diabetes Data-Assisted Remission Trial (DDART)","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2021-06-09","conditions":"Type 2 Diabetes, Obesity","enrollment":65},{"nctId":"NCT05457959","phase":"PHASE1","title":"Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant","status":"WITHDRAWN","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2024-12-01","conditions":"Diffuse Hemispheric Glioma, H3 G34-Mutant","enrollment":""},{"nctId":"NCT06572566","phase":"","title":"Study on Neuropsychiatric Behavior in Cadmium-exposed People","status":"RECRUITING","sponsor":"Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.","startDate":"2024-01-08","conditions":"Cadmium Exceeds the Standard","enrollment":84},{"nctId":"NCT01196715","phase":"PHASE3","title":"Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Barts & The London NHS Trust","startDate":"2010-11-01","conditions":"Myelodysplastic Syndrome","enrollment":360}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard blood components","genericName":"Standard blood components","companyName":"University of Washington","companyId":"university-of-washington","modality":"Biologic","firstApprovalDate":"","aiSummary":"Standard blood components restore normal blood function by replacing deficient or dysfunctional cellular and protein elements. Used for Acute blood loss and hemorrhage, Anemia requiring transfusion, Thrombocytopenia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}